Sally C. Pipes

Commentary

No, $900B in Medicaid Spending Is Not Making Americans Healthier

During his confirmation hearing, Robert F. Kennedy Jr., the incoming secretary of the Department of Health and Human Services, posed a key question about the nation’s largest health insurance program. “Do you think all that money, the $900 billion we’re sending to Medicaid every year, has made Americans healthy?” he ...
Commentary

Congress Eyes Regulating Drug Ads, It Won’t Mean Lower Prices

“Knowing what something costs before buying it is just common sense.” That’s how Sen. Chuck Grassley, R-Iowa, justified a bill he introduced in January to require drug companies to include a medicine’s list price in their advertisements. Unfortunately, his Drug-price Transparency for Consumers, or DTC, Act — co-sponsored by Sen. ...
Commentary

Obamacare insurers collect billions in taxpayer subsidies — just to deny claims

Democrats spent the last four years trying to expand Obamacare enrollment, largely by ramping up federal premium subsidies. However, the health coverage available through the exchanges often doesn’t do much good, as too many Obamacare enrollees discover when a medical bill comes due. Read the op-ed here.
Commentary

The World’s Medicine Chest

Just released from PRI – read The World’s Medicine Chest, the latest book from PRI President, CEO and Thomas W. Smith Fellow in Health Care Policy. The World’s Medicine Chest explores how America became the world’s leader in biopharmaceutical innovation through market capitalism. Click here to register to watch a special live ...
Commentary

Unaffordable Medicaid Means We Should Forget It

U.S. House Republicans recently released a list of proposals for slashing federal spending by as much as $5.7 trillion. A significant portion of the proposed savings — a whopping $2.3 trillion — would come from Medicaid. Progressives are decrying the GOP document as a heartless assault on an essential safety-net ...
Book

Read the new book from Sally Pipes “The World’s Medicine Chest”

Just released from PRI – read The World’s Medicine Chest, the latest book from PRI President, CEO and Thomas W. Smith Fellow in Health Care Policy. <The World’s Medicine Chest explores how America became the world’s leader in biopharmaceutical innovation through market capitalism. Click here to register to watch a special ...
Commentary

Insulin prices are falling due to market forces — no price caps required

California State Sen. Scott Wiener, D-San Francisco, recently introduced legislation that would cap cost-sharing for insulin at $35 a month, regardless of whether a patient has public or private insurance. It’s a popular idea. But it may not be necessary. The cost of insulin has been falling due to market ...
Commentary

The CFPB’s New Medical Debt Rule Will Do More Harm Than Good

The Biden administration issued a flurry of directives in its final days. One move in particular warrants closer inspection. On January 7, the Consumer Financial Protection Bureau finalized a rule barring medical debt from appearing on credit reports. According to the agency, the rule will wipe $49 billion in medical ...
Commentary

Patients Pay Dearly for Biden’s Pricing Mess

On Jan. 17, just days before leaving office, the Biden administration announced the next 15 prescription drugs dispensed through Medicare Part D that will be subject to price controls on Jan. 1, 2027, under the terms of the Inflation Reduction Act. Among them is the blockbuster semaglutide, a prescription medication ...
Commentary

RFK Jr.’s Confirmation Hearings Can’t Leave This Question Unanswered

On this Wednesday and Thursday, two powerful Senate committees will hold confirmation hearings for Robert F. Kennedy Jr., President Trump’s nominee to lead the Department of Health and Human Services. RFK Jr. is no stranger to controversy. But his most radical policy position may be one that relatively few people ...
Commentary

No, $900B in Medicaid Spending Is Not Making Americans Healthier

During his confirmation hearing, Robert F. Kennedy Jr., the incoming secretary of the Department of Health and Human Services, posed a key question about the nation’s largest health insurance program. “Do you think all that money, the $900 billion we’re sending to Medicaid every year, has made Americans healthy?” he ...
Commentary

Congress Eyes Regulating Drug Ads, It Won’t Mean Lower Prices

“Knowing what something costs before buying it is just common sense.” That’s how Sen. Chuck Grassley, R-Iowa, justified a bill he introduced in January to require drug companies to include a medicine’s list price in their advertisements. Unfortunately, his Drug-price Transparency for Consumers, or DTC, Act — co-sponsored by Sen. ...
Commentary

Obamacare insurers collect billions in taxpayer subsidies — just to deny claims

Democrats spent the last four years trying to expand Obamacare enrollment, largely by ramping up federal premium subsidies. However, the health coverage available through the exchanges often doesn’t do much good, as too many Obamacare enrollees discover when a medical bill comes due. Read the op-ed here.
Commentary

The World’s Medicine Chest

Just released from PRI – read The World’s Medicine Chest, the latest book from PRI President, CEO and Thomas W. Smith Fellow in Health Care Policy. The World’s Medicine Chest explores how America became the world’s leader in biopharmaceutical innovation through market capitalism. Click here to register to watch a special live ...
Commentary

Unaffordable Medicaid Means We Should Forget It

U.S. House Republicans recently released a list of proposals for slashing federal spending by as much as $5.7 trillion. A significant portion of the proposed savings — a whopping $2.3 trillion — would come from Medicaid. Progressives are decrying the GOP document as a heartless assault on an essential safety-net ...
Book

Read the new book from Sally Pipes “The World’s Medicine Chest”

Just released from PRI – read The World’s Medicine Chest, the latest book from PRI President, CEO and Thomas W. Smith Fellow in Health Care Policy. <The World’s Medicine Chest explores how America became the world’s leader in biopharmaceutical innovation through market capitalism. Click here to register to watch a special ...
Commentary

Insulin prices are falling due to market forces — no price caps required

California State Sen. Scott Wiener, D-San Francisco, recently introduced legislation that would cap cost-sharing for insulin at $35 a month, regardless of whether a patient has public or private insurance. It’s a popular idea. But it may not be necessary. The cost of insulin has been falling due to market ...
Commentary

The CFPB’s New Medical Debt Rule Will Do More Harm Than Good

The Biden administration issued a flurry of directives in its final days. One move in particular warrants closer inspection. On January 7, the Consumer Financial Protection Bureau finalized a rule barring medical debt from appearing on credit reports. According to the agency, the rule will wipe $49 billion in medical ...
Commentary

Patients Pay Dearly for Biden’s Pricing Mess

On Jan. 17, just days before leaving office, the Biden administration announced the next 15 prescription drugs dispensed through Medicare Part D that will be subject to price controls on Jan. 1, 2027, under the terms of the Inflation Reduction Act. Among them is the blockbuster semaglutide, a prescription medication ...
Commentary

RFK Jr.’s Confirmation Hearings Can’t Leave This Question Unanswered

On this Wednesday and Thursday, two powerful Senate committees will hold confirmation hearings for Robert F. Kennedy Jr., President Trump’s nominee to lead the Department of Health and Human Services. RFK Jr. is no stranger to controversy. But his most radical policy position may be one that relatively few people ...
Scroll to Top